| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Vaxcyte, Inc. (PCVX) has 6 insiders with recent SEC Form 4 filings, including 0 buys and 36 sells. PCVX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| COO | 160.7K | $8.99M | - | |
| CEO | 133.2K | $7.45M | -18,198 | |
| CFO | 106.5K | $5.95M | - | |
| Other | 76.8K | $4.29M | -17,000 | |
| VP | 29.0K | $1.62M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 5, 2025 | Eydelman Mikhail67 | SVP, Gen Counsel &Corp Sec | Sale+OE | 5,000 | $70.74 | $353,699.01 | -3.8% | -53.1% | -21.3% | |
| Mar 3, 2025 | Wassil Jim53 | Chief Operating Officer | Sale+OE | 8,000 | $73.27 | $586,165.11 | -2.5% | -51.4% | -17.0% | |
| Feb 18, 2025 | Guggenhime Andrew46 | President And CFO | Sale+OE | 8,000 | $83.85 | $670,822.74 | -3.5% | -61.2% | -31.9% | |
| Feb 5, 2025 | Eydelman Mikhail67 | SVP, Gen Counsel &Corp Sec | Sale+OE | 5,000 | $90.07 | $450,368.64 | -3.2% | -67.3% | -39.7% | |
| Feb 3, 2025 | Wassil Jim53 | Chief Operating Officer | Sale+OE | 8,000 | $86.22 | $689,790.43 | -1.3% | -59.6% | -34.3% | |
| Jan 21, 2025 | Guggenhime Andrew46 | President And CFO | Sale+OE | 8,000 | $86.51 | $692,100.57 | -2.4% | -65.5% | -43.0% | |
| Jan 15, 2025 | Loxam Teri | Director | Sale+OE | 6,250 | $85.11 | $531,962.92 | -7.1% | -66.1% | -46.2% | |
| Jan 6, 2025 | Eydelman Mikhail67 | SVP, Gen Counsel &Corp Sec | Sale+OE | 5,000 | $85.58 | $427,922.80 | -5.3% | -62.2% | -47.8% | |
| Jan 2, 2025 | Wassil Jim53 | Chief Operating Officer | Sale+OE | 8,000 | $83.66 | $669,266.91 | -1.3% | -59.6% | -44.2% | |
| Dec 18, 2024 | Guggenhime Andrew46 | President And CFO | Sale+OE | 8,000 | $88.78 | $710,248.58 | -1.8% | -12.9% | -49.0% |